10-Q: Hamilton Beach Q3 Revenue Drops 15% Amid Tariff Impact

Hamilton Beach Brands Holding Company reported a 15.2% revenue decline in Q3 2025, primarily due to lower U.S. consumer volumes and tariff impacts, despite improved net income for the nine-month period.

Summary

• Revenue for the three months ended September 30, 2025, decreased by $23.9 million, or 15.2%, to $132.8 million compared to $156.7 million in the prior year, primarily due to lower volumes in the U.S. Consumer business and delayed orders from a large retailer.
• Gross profit margin for Q3 2025 declined to 21.1% from 28.0% in Q3 2024, impacted by a one-time incremental tariff cost of $5.0 million (370 basis points) and a delay in pricing adjustments.
• Selling, general and administrative expenses decreased by $8.2 million in Q3 2025, driven by $6.8 million in lower personnel costs, reduced stock-based compensation, and benefits from Q2 restructuring actions.
• Operating profit for Q3 2025 fell by 72.9% to $2.9 million from $10.6 million in Q3 2024.
• Net income for Q3 2025 was $1.7 million, a 14.6% decrease from $1.9 million in Q3 2024.
• For the nine months ended September 30, 2025, revenue decreased by $47.3 million, or 10.7%, to $393.9 million.
• Nine-month gross profit margin decreased to 24.4% from 25.9% in the prior year, with a $5.0 million tariff cost impacting margin by 130 basis points.
• Nine-month net income increased by 17.0% to $7.9 million in 2025 from $6.8 million in 2024, partly due to a lower effective tax rate of 25.1% (vs. 34.7% in 2024).
• Net cash used for operating activities was $14.6 million for the nine months ended September 30, 2025, a $49.8 million decrease from cash provided of $35.2 million in the prior year, mainly due to reduced accounts payable and changes in other assets/liabilities.
• The Health segment, acquired in February 2024, reported Q3 2025 revenue of $1.9 million and operating profit of $0.3 million, an improvement from an operating loss of $1.1 million in Q3 2024.
• The company repurchased 39,333 shares for $0.6 million in Q3 2025 and 396,065 shares for $7.2 million for the nine months ended September 30, 2025, under its $25 million stock repurchase program, with $4.2 million remaining authorized.

Sentiment

Score: 3

Explanation: The company faced significant headwinds in Q3 2025, with substantial revenue and operating profit declines driven by lower consumer demand and tariff costs. While SG&A reductions and HealthBeacon's Q3 operating profit improvement are positive, the overall financial performance for the quarter and the negative operating cash flow for the nine-month period indicate considerable challenges.

Positives

• Net income for the nine months ended September 30, 2025, increased by 17.0% to $7.9 million, compared to $6.8 million in the prior year.
• Selling, general and administrative expenses decreased significantly by $8.2 million in Q3 2025 and $10.0 million for the nine months, primarily due to lower personnel costs and benefits from restructuring actions.
• The Health segment's operating profit improved to $0.3 million in Q3 2025 from a loss of $1.1 million in Q3 2024, indicating progress in the acquired business.
• The effective income tax rate was lower at 18.4% in Q3 2025 (vs. 27.4% in Q3 2024) and 25.1% for the nine months (vs. 34.7% in 9M 2024), driven by increased foreign derived tax benefits and reduced foreign losses.
• The company maintains sufficient liquidity with $66.1 million in Excess Availability under its $125.0 million revolving credit facility as of September 30, 2025.
• The company continues its stock repurchase program, demonstrating a commitment to returning capital to shareholders, with $4.2 million remaining authorized.

Negatives

• Revenue decreased substantially by 15.2% in Q3 2025 and 10.7% for the nine months ended September 30, 2025, primarily due to lower U.S. Consumer business volumes and retailer inventory adjustments.
• Gross profit margin significantly contracted to 21.1% in Q3 2025 from 28.0% in Q3 2024, largely due to a $5.0 million incremental tariff cost and a delay in implementing pricing adjustments.
• Operating profit declined sharply by 72.9% in Q3 2025 and 43.3% for the nine months ended September 30, 2025.
• Net cash used for operating activities was $14.6 million for the nine months ended September 30, 2025, a significant reversal from $35.2 million cash provided in the prior year, reflecting lower purchasing activity and pension surplus use.
• Inventory levels increased to $174.8 million as of September 30, 2025, from $124.9 million at December 31, 2024, despite decreased sales volume.

Risks

• Uncertain or unfavorable global economic conditions, including impacts from tariffs, inflation, rising interest rates, recessions, or economic slowdowns.
• Changes in costs, including transportation costs and tariffs, of sourced products, and the company's ability to pass these costs to customers.
• Ability to source and ship products to meet anticipated demand, and changes in or unavailability of quality or cost-effective suppliers.
• Constraints throughout the global transportation supply chain and delays in delivery of sourced products.
• Changes in sales prices, product mix, or levels of consumer purchases of small electric and specialty housewares appliances.
• Changes in consumer retail and credit markets, including the increasing volume of transactions made through third-party internet sellers.
• Bankruptcy of or loss of major retail customers or suppliers.
• Exchange rate fluctuations, changes in import tariffs, monetary policies, and other changes in the regulatory climate in countries of operation.
• Customer acceptance of changes in costs of or delays in the development of new products.
• Product liability, regulatory actions or other litigation, warranty claims, or returns of products.
• Increased competition, including consolidation within the industry.
• Changes in customers' inventory management strategies, leading to delayed orders or reduced purchasing.
• Shifts in consumer shopping patterns, gasoline prices, weather conditions, consumer confidence, and disposable income.
• Changes mandated by federal, state, and other regulation, including tax, health, safety, or environmental legislation.
• Ability to identify, acquire or develop, and successfully integrate, new businesses or new product lines.

Future Outlook

The company anticipates its revenue will typically increase during the second half of the year, peaking in the fourth quarter due to the fall holiday-selling season. The adoption of ASU 2023-09 is not expected to have a material impact on consolidated financial statements. The recently enacted One Big Beautiful Bill Act (OBBBA) is expected to reduce federal income tax liability and related tax payments for current and future years, though it will not significantly impact the annual effective tax rate. HealthBeacon will be fully integrated into management's evaluation of internal control over financial reporting as of December 31, 2025.

Management Comments

• "The revenue decline was primarily driven by lower volumes in the Company's U.S. Consumer business, including a delay in orders from one large retailer for most of the third quarter as they assessed inventory levels and pricing in response to the tariffs implemented by the U.S. in April 2025."
• "The decrease [in SG&A] was primarily driven by $6.8 million of lower personnel costs, including reduced stock-based compensation expense due to changes in stock price and benefits associated with the restructuring actions taken by management in the second quarter."

Industry Context

The market for small electric household and specialty housewares appliances typically sees increased revenue in the second half of the year, peaking in the fourth quarter due to the fall holiday-selling season. The company's performance reflects broader industry challenges, including the impact of U.S. tariffs on imports from China, which led to temporary spikes in tariff rates and caused retailers to pause buying and reassess inventory levels and pricing. This indicates a cautious retail environment and supply chain adjustments across the consumer goods sector.

Corporate Governance

Legal Proceedings

• The company is involved in various legal and regulatory proceedings and claims that have arisen in the ordinary course of business, including product liability, patent infringement, environmental, and other claims.
• Accrued undiscounted obligations of $3.0 million as of September 30, 2025, for environmental investigation and remediation activities.
• It is reasonably possible that the company may incur additional expenses in the range of zero to $1.0 million related to environmental investigation and remediation at these sites.
• As of September 30, 2025, the company has a $0.6 million asset associated with the reimbursement of costs for two environmental sites.

Stakeholder Impact

• Shareholders: Experienced a decrease in Q3 net income and EPS, but an increase in 9-month net income. The ongoing stock repurchase program aims to return capital, and dividends were paid.
• Employees: Personnel costs were reduced, including stock-based compensation, due to restructuring actions. The U.S. Pension Plan termination was substantially completed, with surplus assets transferred to a qualified replacement plan for future benefits.
• Customers: Faced pricing adjustments and delays in orders, particularly from a large retailer, due to tariff impacts and inventory assessments.
• Suppliers: Experienced lower purchasing activity from the company due to decreased sales volume and inventory turnover. New suppliers under China diversification initiatives have shorter payment terms.
• Creditors: The company utilized its revolving credit facility, with $50.0 million outstanding, but remains in compliance with all applicable financial covenants.

Next Steps

• The company plans to adopt ASU 2023-09 prospectively with retrospective application for annual periods beginning after December 15, 2024.
• The company is currently evaluating the impact of ASU 2024-03, which is effective for fiscal years beginning after December 15, 2026, and interim periods beginning after December 15, 2027.
• HealthBeacon will be included in management's evaluation of internal control over financial reporting as of December 31, 2025.
• The stock repurchase program for up to $25 million of Class A Common stock will continue until December 31, 2025, with $4.2 million remaining authorized for repurchase.

Key Dates

Recommendation

While Hamilton Beach Brands Holding Company experienced significant revenue and operating profit declines in Q3 2025 due to U.S. consumer softness and tariff impacts, the nine-month net income showed an increase, and SG&A expenses were reduced. The HealthBeacon segment also showed improved operating profit in Q3. The company is actively managing its capital through share repurchases and maintains sufficient liquidity. However, the ongoing challenges from tariffs, inventory management by retailers, and negative operating cash flow warrant a cautious approach. A "hold" recommendation is appropriate as investors should monitor the effectiveness of pricing adjustments, the resolution of tariff impacts, and the continued integration and performance of the Health segment before making further investment decisions.

Keywords

Small Appliances, Housewares, Commercial Products, HealthTech, SEC Filing, 10-Q, Hamilton Beach, HBB, Consumer Goods, Tariffs, Supply Chain, Financial Results, Earnings, Revenue, Profit, Cash Flow